Showing results (211-220 of 6,664) with videos related to
Sort By:
Pageof 667
Annals of Hematology|March 17, 2006
Analysis of MTHFR polymorphisms and P16 methylation and their correlation with clinical-biological features of multiple myelomaPatrizia Chiusolo, Giuliana Farina, Rossana Putzulu, et al.Annals of Hematology|October 6, 1998
Antisense strategies for the treatment of hematological malignancies and solid tumorsR Kronenwett, R HaasAnnals of Hematology|October 6, 1998
Time after bone marrow transplantation as an important variable for quality of life: results of a cross-sectional investigation using two different instruments for quality-of-life assessmentM Kopp, H Schweigkofler, B Holzner, et al.Annals of Hematology|January 6, 1999
Phenotype variability of the dominant beta-thalassemia induced in four Dutch families by the rare cd121 (G-->T) mutationP C Giordano, C L Harteveld, J J Michiels, et al.Annals of Hematology|January 6, 1999
Prevalence and molecular characterization of beta-thalassemia in FilipinosT M Ko, A P Caviles, H L Hwa, et al.Annals of Hematology|January 6, 1999
Different binding mechanisms of myeloid leukemic cells to adhesion molecules on bone marrow stromal fibroblasts induced by TNF-alpha and IL-4B Stolze, W Ebell, K WelteAnnals of Hematology|January 4, 2006
Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell cultureRamida Watanapokasin, Duangmanee Sanmund, Pranee Winichagoon, et al.Annals of Hematology|January 5, 2006
Soluble c-kit ligand production by bone marrow stromal cells is independent of the degree of neutropenia in patients with chronic idiopathic neutropeniaHelen A Papadaki, Charalampos Pontikoglou, Emily Stavroulaki, et al.Annals of Hematology|January 5, 2006
Molecularly targeted therapies in myelodysplastic syndromes and acute myeloid leukemiasMichael A Morgan, Christoph W M ReuterAnnals of Hematology|January 13, 2006
Erythropoietin plus granulocyte colony-stimulating factor is better than erythropoietin alone to treat anemia in low-risk myelodysplastic syndromes: results from a randomized single-centre studyEnrico Balleari, Edoardo Rossi, Marino Clavio, et al.Pageof 667